579 results
Page 17 of 29
6-K
EX-99.1
4l82iuq90u snmh8
8 Mar 12
Teva and OncoGenex Announce Updates to Custirsen Development Program in Advanced Prostate Cancer
12:00am
6-K
EX-99.1
iy9q8oj
5 Mar 12
Late Stage Data Demonstrated Long-Term Nasal Symptom Relief and Improvement in Quality of Life
12:00am
6-K
EX-99.1
8snikd7ut98s1 5i
2 Mar 12
Teva Announces Launch of Generic Prometrium® Capsules in the United States
12:00am
6-K
l5l1vxj
15 Feb 12
Teva Pharmaceutical Industries Limited 6-K
12:00am
6-K
EX-99.1
g3bcidl0ewa1
17 Jan 12
Live Filing
12:00am
6-K
EX-99.1
so6ar7u40q31y jmk
3 Jan 12
Teva Announces Management Succession
12:00am
6-K
EX-99.1
9odsr1
3 Jan 12
Live Filing
12:00am
6-K
EX-99.1
eu6gr
21 Dec 11
Teva Provides 2012 Non-GAAP Financial Outlook; 2012 Non-GAAP Diluted EPS of $5.48 to $5.68
12:00am
6-K
EX-99.1
3l34rlablx50 nv8wgy
2 Dec 11
Live Filing
12:00am
6-K
EX-99.1
b3gbwyn14bg 788n5q
1 Dec 11
Live Filing
12:00am
6-K
EX-1.2
bpy280
10 Nov 11
Current report (foreign)
12:00am
6-K
EX-1.1
2a4hht2t
10 Nov 11
Current report (foreign)
12:00am
6-K
EX-1.3
e9cn2e
10 Nov 11
Current report (foreign)
12:00am
6-K
EX-99.1
wh7ujkbhibei7
8 Nov 11
Teva Announces Pricing of $5,000,000,000 of Senior Notes
12:00am
424B5
g2mjfq txaea0zt36
8 Nov 11
Prospectus supplement for primary offering
12:00am
424B5
t7i xksfl3p2rucxey
7 Nov 11
Prospectus supplement for primary offering
12:00am
6-K
ofjhbg9nf3nnjhjnp2
2 Nov 11
Current report (foreign)
12:00am
6-K
EX-2.2
xwg27 2ec
2 Nov 11
Current report (foreign)
12:00am
6-K
8be izf4s
2 Nov 11
Teva Pharmaceutical Industries Limited 6-K
12:00am